{"brief_title": "A Safety and Efficacy Study of Hospitalized Patients With Community-Acquired Pneumonia and Sepsis", "brief_summary": "The objective of this study is to demonstrate the safety and efficacy of IC14 in the treatment of hospitalized patients with community-acquired pneumonia and sepsis.", "condition": "Sepsis", "intervention_type": "Drug", "intervention_name": "Recombinant Chimeric Monoclonal Antibody", "criteria": "Inclusion Criteria: - Current diagnosis of community-acquired pneumonia. - Evidence of systemic inflammatory response to infection. Exclusion Criteria: - Atypical or viral pneumonia based on clinical or epidemiologic suspicion by the investigator. - Presence of organ failure.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "id": "NCT00042588.xml"}